ARGA Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,009
| Closed | -$1.55M | – | 129 |
|
|
2025
Q2 | $1.55M | Sell |
14,009
-3,610
| -20% | -$384K | 0.04% | 55 |
|
|
2025
Q1 | $1.97M | Sell |
17,619
-163,251
| -90% | -$16.8M | 0.07% | 39 |
|
|
2024
Q4 | $16.7M | Sell |
180,870
-683,916
| -79% | -$61.6M | 0.55% | 23 |
|
|
2024
Q3 | $72.5M | Buy |
864,786
+2,959
| +0.3% | +$226K | 2.4% | 14 |
|
|
2024
Q2 | $59.1M | Buy |
861,827
+226,769
| +36% | +$15.1M | 2.08% | 15 |
|
|
2024
Q1 | $46.5M | Hold |
635,058
| – | – | 1.56% | 24 |
|
|
2023
Q4 | $51.4M | Buy |
635,058
+37,069
| +6% | +$2.88M | 1.78% | 17 |
|
|
2023
Q3 | $44.8M | Buy |
597,989
+118,206
| +25% | +$9.09M | 1.82% | 16 |
|
|
2023
Q2 | $37M | Buy |
479,783
+24,654
| +5% | +$1.97M | 1.31% | 19 |
|
|
2023
Q1 | $37.8M | Buy |
455,129
+14,249
| +3% | +$1.18M | 1.41% | 16 |
|
|
2022
Q4 | $37.8M | Sell |
440,880
-51,254
| -10% | -$4.06M | 1.61% | 15 |
|
|
2022
Q3 | $30.4M | Sell |
492,134
-103,927
| -17% | -$6.55M | 1.65% | 19 |
|
|
2022
Q2 | $36.8M | Hold |
596,061
| – | – | 2.03% | 11 |
|
|
2022
Q1 | $35.4M | Buy |
596,061
+196,253
| +49% | +$12.5M | 1.94% | 14 |
|
|
2021
Q4 | $29M | Buy |
399,808
+293,505
| +276% | +$20.2M | 1.85% | 16 |
|
|
2021
Q3 | $7.42M | Buy |
106,303
+2,236
| +2% | +$157K | 0.52% | 18 |
|
|
2021
Q2 | $7.17M | Buy |
104,067
+7,560
| +8% | +$505K | 0.57% | 18 |
|
|
2021
Q1 | $6.24M | Buy |
96,507
+68,672
| +247% | +$4.43M | 0.47% | 20 |
|
|
2020
Q4 | $1.62M | Buy |
27,835
+3,001
| +12% | +$181K | 0.1% | 43 |
|
|
2020
Q3 | $1.57M | Sell |
24,834
-17,341
| -41% | -$1.2M | 0.14% | 32 |
|
|
2020
Q2 | $3.25M | Sell |
42,175
-25,754
| -38% | -$1.97M | 0.36% | 23 |
|
|
2020
Q1 | $5.08M | Buy |
67,929
+53
| +0.1% | +$3.66K | 0.88% | 15 |
|
|
2019
Q4 | $4.41M | Buy |
67,876
+29,200
| +75% | +$1.9M | 0.5% | 18 |
|
|
2019
Q3 | $2.45M | Buy |
38,676
+347
| +0.9% | +$22.7K | 0.31% | 29 |
|
|
2019
Q2 | $2.59M | Sell |
38,329
-3,775
| -9% | -$248K | 0.38% | 25 |
|
|
2019
Q1 | $2.74M | Buy |
42,104
+5,975
| +17% | +$397K | 0.41% | 26 |
|
|
2018
Q4 | $2.26M | Sell |
36,129
-16,725
| -32% | -$1.17M | 0.37% | 31 |
|
|
2018
Q3 | $4.08M | Sell |
52,854
-5,300
| -9% | -$400K | 0.57% | 17 |
|
|
2018
Q2 | $4.12M | Buy |
58,154
+5,250
| +10% | +$371K | 0.51% | 21 |
|
|
2018
Q1 | $3.99M | Buy |
52,904
+4,425
| +9% | +$352K | 0.45% | 19 |
|
|
2017
Q4 | $3.47M | Sell |
48,479
-4,150
| -8% | -$315K | 0.39% | 23 |
|
|
2017
Q3 | $4.26M | Buy |
52,629
+8,600
| +20% | +$658K | 0.51% | 20 |
|
|
2017
Q2 | $3.12M | Buy |
44,029
+6,530
| +17% | +$435K | 0.43% | 30 |
|
|
2017
Q1 | $2.55M | Buy |
37,499
+8,629
| +30% | +$607K | 0.36% | 26 |
|
|
2016
Q4 | $2.07M | Buy |
+28,870
| New | +$2.15M | 0.46% | 25 |
|
Other funds holding GILD
ARGA Investment Management's GILD Position: Q3 2025 in Review
ARGA Investment Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 14,009 shares — an estimated $1.55M sold.
ARGA Investment Management first reported a position in GILD in Q4 2016 and held it in 35 quarters. The position peaked at $72.5M in Q3 2024. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- ARGA Investment Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- ARGA Investment Management sold 14,009 Gilead Sciences shares in Q3 2025, an estimated $1.55M.
- ARGA Investment Management first reported a position in Gilead Sciences in Q4 2016 and held it in 35 quarters.
- ARGA Investment Management's Gilead Sciences position peaked at $72.5M in Q3 2024.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on ARGA Investment Management's 13F filing for Q3 2025, filed 31 Oct 2025.